KalVista Pharmaceuticals Ownership | Who Owns KalVista Pharmaceuticals?
KalVista Pharmaceuticals Ownership Summary
KalVista Pharmaceuticals is owned by 104.70% institutional investors, 1.36% insiders. Vr adviser is the largest institutional shareholder, holding 13.38% of KALV shares. American Funds SMALLCAP World A is the top mutual fund, with 6.83% of its assets in KalVista Pharmaceuticals shares.
KALV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | KalVista Pharmaceuticals | 104.70% | 1.36% | -6.07% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vr adviser | 6.25M | 13.38% | $52.94M |
| Suvretta capital management | 4.91M | 10.52% | $41.61M |
| Tang capital management | 4.89M | 10.48% | $41.45M |
| Vestal point capital, lp | 4.77M | 10.22% | $40.40M |
| Frazier life sciences management | 3.69M | 8.46% | $43.44M |
| Capital world investors | 3.37M | 7.23% | $28.58M |
| Blackrock | 2.95M | 6.76% | $34.69M |
| Blackrock funding, inc. /de | 2.86M | 6.13% | $24.26M |
| Vanguard group | 2.26M | 4.83% | $19.10M |
| Great point partners | 1.79M | 3.83% | $15.14M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Great point partners | 1.79M | 7.13% | $15.14M |
| Allostery investments lp | 479.10K | 4.24% | $4.06M |
| Vr adviser | 6.25M | 3.63% | $52.94M |
| Tang capital management | 4.89M | 2.74% | $41.45M |
| Vestal point capital, lp | 4.77M | 2.40% | $40.40M |
| Stempoint capital lp | 992.80K | 2.10% | $8.41M |
| Frazier life sciences management | 3.69M | 2.03% | $43.44M |
| Octagon capital advisors lp | 1.37M | 1.91% | $11.60M |
| Saturn v capital management | 556.49K | 1.85% | $4.71M |
| Dafna capital management | 811.68K | 1.75% | $6.87M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | 1.37M | 1.91% | 1.37M |
| Stempoint capital lp | 992.80K | 2.10% | 992.80K |
| Vestal point capital, lp | 4.77M | 2.40% | 770.00K |
| Suvretta capital management | 4.91M | 1.42% | 701.01K |
| Woodline partners lp | 1.29M | 0.07% | 680.15K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | - | - | -1.16M |
| Adage capital partners gp | 300.00K | 0.00% | -1.12M |
| Bioimpact capital | - | - | -896.91K |
| Driehaus capital management | - | - | -535.72K |
| Perceptive advisors | - | - | -500.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Octagon capital advisors lp | 1.37M | 1.91% | 1.37M | $11.60M |
| Allostery investments lp | 479.10K | 4.24% | 479.10K | $4.06M |
| Walleye capital | 267.74K | 0.01% | 267.74K | $2.27M |
| Norges bank | 131.30K | 0.00% | 131.30K | $1.55M |
| Susquehanna fundamental investments | 80.32K | 0.01% | 80.32K | $680.30K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Fortitude family office | -3.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Farther finance advisors | -13.00 |
| Creekmur asset management | -23.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 126 | 0.80% | 48,891,669 | 0.99% | 104 | 0.95% | 71 | 4.41% | 31 | 3.33% |
| Sep 30, 2024 | 125 | 2.46% | 48,412,312 | 0.37% | 104 | 0.86% | 68 | 7.94% | 30 | -9.09% |
| Jun 30, 2024 | 122 | -7.58% | 48,235,227 | 2.65% | 110 | 0.95% | 63 | -20.25% | 33 | -8.33% |
| Mar 31, 2024 | 132 | 24.53% | 46,987,795 | 27.12% | 107 | 0.95% | 79 | 25.40% | 36 | 80.00% |
| Dec 31, 2023 | 106 | -4.50% | 36,964,765 | 1.93% | 106 | 0.97% | 63 | 18.87% | 20 | -23.08% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 3.37M | 6.83% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.40M | 2.83% | - |
| Vanguard US Total Market Shares ETF | 1.20M | 2.41% | - |
| International Biotechnology Ord | 1.08M | 2.19% | 6.16K |
| iShares Russell 2000 ETF | 1.01M | 2.04% | -8.74K |
| Vanguard Institutional Extnd Mkt Idx Tr | 546.54K | 1.10% | 1.50K |
| Emerald Growth A | 357.34K | 0.72% | - |
| iShares Russell 2000 Growth ETF | 339.46K | 0.68% | -1.62K |
| Fidelity Small Cap Index | 332.64K | 0.67% | -6.23K |
| SPDR® S&P Biotech ETF | 321.79K | 0.65% | -3.46K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 09, 2025 | Venrock Healthcare Capital Partners III, L.P. | - | Buy | $235.50K |
| Mar 07, 2025 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | $79.83K |
| Feb 24, 2025 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | $23.99K |
| Feb 24, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | $19.22K |
| Feb 18, 2025 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | $25.55K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 1 | - |
| 2025 Q1 | 8 | 6 |
| 2024 Q4 | - | 6 |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 5 |
KALV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools